Showing 4 of 4 recruiting trials for “Primary hyperoxaluria”
Phase 1/2 Study of ABO-101 in Primary Hyperoxaluria Type 1 (redePHine)
Clinical Exploration Study of YOLT-203 in the Treatment of Type 1 Primary Hyperoxaluria (PH1)
RecruitingNCT06225882 ↗
Retrospective and Prospective Follow-up of Patients With Primary Hyperoxaluria Type 1 Treated With Lumasiran in France.
Safety & Efficacy of DCR-PHXC in Patients With PH1 and ESRD
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →